This inventor holds 1 USPTO granted patent. Top assignee: General Electric Company. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Guido Schwartenbeck: Innovator in Radiopharmaceutical Measurement
Introduction
Guido Schwartenbeck is a notable inventor based in Munster, Germany. He has made significant contributions to the field of radiopharmaceuticals, particularly in the measurement of radioactivity concentration. His innovative work has implications for both medical and research applications.
Latest Patents
Guido Schwartenbeck holds a patent for a "System and method for measurement of radioactivity concentration of a radiopharmaceutical." This patent describes a system that includes a vial for receiving a radioactive tracer solution and a buffer solution. The system is equipped with a scale and a radioactivity measuring device, along with a controller that calculates the radioactive concentration based on the measured radioactivity and weight of the solutions in the vial. The method involves transferring the tracer solution into a vial, measuring its radioactivity, determining the necessary weight for a desired concentration, and diluting the solution with a buffer.
Career Highlights
Guido Schwartenbeck is associated with General Electric Company, where he applies his expertise in radiopharmaceuticals. His work has been instrumental in advancing measurement techniques that enhance the accuracy and reliability of radioactivity assessments.
Collaborations
He has collaborated with colleagues such as Stefan Riese and Michael Brussermann, contributing to a dynamic work environment that fosters innovation and development in their field.
Conclusion
Guido Schwartenbeck's contributions to the measurement of radioactivity concentration in radiopharmaceuticals highlight his role as an important inventor in the medical technology sector. His patent and collaborative efforts continue to influence advancements in this critical area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
